Kinetics of Prion Growth  by Pöschel, Thorsten et al.
3460 Biophysical Journal Volume 85 December 2003 3460–3474
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Humboldt-Universita¨t zu Berlin, Charite´, Institut fu¨r Biochemie, Berlin, Germany
ABSTRACT We study the kinetics of prion ﬁbril growth, described by the nucleated polymerization model analytically and by
means of numerical experiments. The elementary processes of prion ﬁbril formation lead us to a set of differential equations for
the number of ﬁbrils, their total mass, and the number of prion monomers. In difference to previous studies we analyze this set
by explicitly taking into account the time-dependence of the prion monomer concentration. The theoretical results agree with
experimental data, whereas the generally accepted hypothesis of constant monomer concentration leads to a ﬁbril growth
behavior which is not in agreement with experiments. The obtained size distribution of the prion ﬁbril aggregates is shifted
signiﬁcantly toward shorter lengths as compared to earlier results, which leads to a enhanced infectivity of the prion material.
Finally, we study the effect of ﬁltering of the inoculated material on the incubation time of the disease.
INTRODUCTION
Although the detailed mechanism for the spreading of
transmittable spongiform encephalopathies diseases (TSE)
such as scrapie, kuru, and a kind of Creutzfeld-Jacob disease
is not yet convincingly clariﬁed, by now it is generally
acknowledged that prion proteins are involved in all forms of
TSE diseases (e.g., Laplanche et al., 1999; Will et al., 1999;
Parchi et al., 1996). There is a long history of speculations,
starting as early as 1967 (Alper et al., 1967; Grifﬁth, 1967),
on whether the presence of misfolded and ﬁbril-like
structure-forming prions cause the disease or whether they
are just a side effect accompanying the disease. By now,
however, there is still no rigorous experimental proof of any
of these hypotheses.
The prion involved in TSE diseases is the PrP protein
(Prusiner, 1991). It is found in two distinct conformations,
PrPc and PrPsc. The proteins of PrPc (c for cellular)
conformation are located at the surface of neural tissues,
but their function has not yet been revealed. In difference to
the healthy conformation, PrPc, the pathogenetic conforma-
tion of this protein, called PrPsc (sc for scrapie), is only
partially digested by proteinase K. The most striking feature
of PrPsc is that it tends to form large-scale aggregates (Jeffrey
et al., 1995) comprising ;200 monomeric units (Prusiner,
1999a). These ﬁbrillic aggregates are essentially one-
dimensional structures (Jarrett and Lansbury, 1993; Lans-
bury and Caughey, 1995), whose sizes grow along one
dimension in both linear directions (Scheibel et al., 2001).
For the molecular mechanism of the conversion of the
healthy PrPc molecule into the pathological PrPsc several
models have been proposed, such as the hetero-dimer
mechanism (Cohen et al., 1994), the cooperative autocatal-
ysis (Eigen, 1996), and the nucleated polymerization model
(Jarrett and Lansbury, 1993). In a critical comparison of
these models, Masel and co-workers gave arguments in favor
of the nucleated polymerization model (Masel et al., 1999),
which by now seems to be widely accepted. Since the kinetic
theory which will be presented in the following sections
applies to this model, we wish to brieﬂy sketch it here: it is
assumed that, in the PrPc conformation, prions occur as
monomers, whereas aggregates consist of PrPsc. The process
of polymerization is assumed to be extremely slow until
a threshold size of n monomers in the aggregate is achieved.
Above this critical size the polymer is much more stable, and
the polymerization progresses signiﬁcantly faster (Lansbury
and Caughey, 1995). PrPsc polymers are assumed to be un-
branched, i.e., they are effectively one-dimensional. It does
not necessarily mean, however, that the PrPsc macromole-
cules are one-monomer wide; i.e., they may well have heli-
cal or similar structure.
Hence, the model by Masel et al. (1999) addresses the
evolution of the disease after an external infection. It does
not describe the aggregate formation by polymerization of
monomers, i.e., the appearance of sporadic prion diseases.
The evolution of the disease after an infection can be de-
scribed separately since the polymerization of monomers (to
form stable aggregate of supercritical size) is a very slow
process. Aggregates which contain a number of monomers
less than n are energetically unfavorable, inasmuch as they
cannot form a stable fold such as a complete b-helix (Wille
et al., 2002). Therefore it is assumed that, once created,
subcritical aggregates disintegrate almost immediately into
monomers.
Thus, the following elementary processes are involved in
the kinetic model by Masel et al. (1999):
1. The system contains a variable number x of PrPc
monomers. They are generated at a time-independent
rate l. Each PrPc monomer is degraded metabolically at
rate d. Thus, by generation, one obtains x ! x 1 1, by
degradation x ! x  1.
2. Each of the linear PrPsc polymers grows by one monomer
unit with rate b. If we denote the number of PrPsc
molecules of length i by yi, then growth of a polymer of
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length i by incorporating a monomer causes yi ! yi  1,
yi11 ! yi11 1 1, and x ! x  1.
3. Any PrPsc polymer of size i may split into two smaller
polymers. Inasmuch as a linear polymer of length i has
i – 1 links connecting monomeric units and each of them
may break at rate b, a PrPsc polymer splits at rate b(i – 1)
into two smaller pieces of lengths j 2 [1, i – 1] and i – j. If
the length of one or both of the fragment polymers is
smaller than the minimal stable polymer size n, this
fragment(s) disintegrates into PrPc monomers. The latter
process is assumed to occur very rapidly, i.e., an inﬁnite
rate is assumed.
Hence, the split of a polymer of size i into two smaller
pieces of sizes j and i – j causes the following changes of
the system’s status:
(a) if j $ n and i – j $ n: yi ! yi  1, yj ! yj1 1,
yij ! yij1 1, or
(b) if j \ n and i – j $ n: yi ! yi  1, yij !
yij1 1, x ! x1 j, or
(c) if j $ n and i – j\ n: yi ! yi  1, yj ! yj1 1,
x ! x1 i j, or
(d ) if j\ n and i – j\ n: yi ! yi  1, x ! x1 i.
Note that the last rule, (d ), deviates from the model
proposed by Masel et al. (1999). In their model, the case
j \ n and i – j \ n was not explicitly considered. If
a polymer of size smaller than 2n – 2 splits it may happen
that both of the arising smaller polymers are shorter than
the minimum stable length n. If one does not take into
account rule (d ), only one of them disintegrates into
monomers—which is inconsistent with the assumption
that polymers shorter than n are unstable. By means of
rule (d ), we assure that both polymers disintegrate,
provided both of them are smaller than n.
4. A PrPsc polymer may be degraded by incorporation into
plaques or by engulfment by macrophages. This process
is independent of the size of the polymer and occurs at
rate a. Here the transition yi ! yi  1 occurs.
The described prion growth model is sketched in Fig. 1.
The aim of this article is to outline some consequences
which follow from the mathematical analysis of the
nucleated polymerization model of PrPsc molecule growth.
In particular we show that there exists a stable steady-state
normalized size distribution of PrPsc polymers for which
we provide an explicit analytical expression. We describe
quantitatively the dynamics of the average size of PrPsc
polymers and give evidence for qualitatively different
scenarios of the disease which happen after an inoculation
of PrPsc into a healthy organism. We derive a condition
which discriminates the scenario of healing, when the initial
number of PrPsc molecules due to the inoculation decays to
zero, from different scenarios. In difference to earlier results
we give evidence that asymptotically the exponential growth
of the total PrPsc mass ceases and the system ﬁnally relaxes
to a steady state with a well-deﬁned size distribution of
polymers. In this steady state the numbers yk of polymers of
lengths k is constant, as well as the number of monomers.
The steady state of the system is determined by the rate
constants a, b, and b, but not by l and d, which characterize
the monomer production and degradation, even if both of
these rates are large as compared to other rates in the system.
We wish to note that although the nucleated polymeriza-
tion model by Masel et al. (1999) is widely accepted, there
exist also alternative models of the prion-related diseases.
Wille et al. (2002) claimed that the formation of aggregates is
not the main process in such diseases and that nonﬁbrillar
structures of the PrPsc may be important. The authors em-
phasized that the conversion of PrPc into PrPsc is driven by
the formation of unusually stable parallel b-helix folds. Serio
et al. (2000) proposed a conformational conversion model,
which incorporates both the aspects of the nucleated
polymerization and templated assembly models (Prusiner,
1999b) with some additional features. The authors suggest
that the appearance of the ﬁbrillar structures during prion-
related diseases happens due to the aggregation of oligo-
meric intermediates.
DERIVATION OF THE KINETIC EQUATIONS
Consider the rate equations for all species involved in the
dynamics of PrPsc growth. The numbers in curled brackets,
f. . .g, refer to the enumeration of the elementary processes
as described in the previous section. We denote the time-
dependent number of PrPc monomers by x(t), and of PrPsc
polymers by yk(t) with k being the degree of polymerization,
i.e., the length of the polymer.
In what follows we do not consider spatial effects for the
reaction kinetics, i.e., we assume that the above-mentioned
elementary processes occur independently of the spatial
location of the polymers and monomers. A complete model
should account for such spatial effects and describe the
transport of monomers and polymers of different sizes in the
organism. Spatial effects may affect the reaction rates
considerably. Moreover such effects as the spread of the
infection from the place of injection to the place of
observation (which may cause a time lag in the evolution
FIGURE 1 Sketch of the prion aggregate growth model after Masel et al.
(1999) but modiﬁed. For explanation see text.
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of the disease) need to be considered by a model which takes
into account spatial effects. Presently, however, we do not
have a reliable model of the molecular transport in the
organism and thus we restrict ourselves to the here-presented
simpliﬁed model.
The PrPc monomer equation
According to the model by Masel et al. (1999) there are two
different source terms for x(t), namely the generation of PrPc
monomers with rate l f1g and disintegration of split prod-
ucts of length smaller than n f3b,3c,3dg. Sink terms for
PrPc monomers are caused by metabolic degradation at rate
d f1g and by PrPsc polymer growth f2g. Mathematically,
the rate equation for PrPc monomers that takes into account
these four processes reads
dx
dt
¼ l dx  bx+
‘
i¼n
yi1 2b +
n1
j¼1
+
‘
i¼n1j
jyi1 2b +
n1
j¼1
+
n1j1
i¼n
iyi:
(1)
The meaning of the ﬁrst two terms at the right-hand side of
Eq. 1 is obvious. The third term describes aggregation of
monomers with polymers of different sizes, where one has to
take into account all existing degrees of polymerization,
starting from i ¼ n, since polymers of size smaller than n are
unstable.
The instability of polymers smaller than n is explicitly
accounted by the following two terms: the index j refers to
the size of one piece after the fracture of a polymer of size i
(which occurs in yi copies). For j ¼ 1; 2; . . . ; n 1, this
piece disintegrates and produces jmonomers. Since the piece
of size j may be split from both sides of the polymer, the
breakage rate constant b doubles in Eq. 1. It is assumed that
a polymer of length i can split at i – 1 positions and all of
these splittings occur with equal rate b. This term describes
the process when only one of the fragments is smaller than n,
whereas the other one of size i – j$ n is stable. The last term
in Eq. 1 accounts for the process when both products of the
splitting process are smaller than n. In this case both of the
resulting polymers are completely disintegrated and, thus,
produce i monomers. Note that in the mathematical
formulation of the model given by Masel et al. (1999) the
possibility of complete disintegration of the polymer after
splitting was not taken into account and the equation for the
monomers derived there lacks the corresponding term. At
ﬁrst glance, this term that concerns only polymers of lengths
smaller than 2n – 2, should not essentially affect the
distribution yi(t). The term matters, however, since splitting
such a small molecule due to the original rule would produce
a number of PrPc monomers and a PrPsc polymer of length
smaller than n which is assumed to be unstable by deﬁnition.
Hence, neglecting this term any simulation would produce
polymers of size smaller than n and, hence, lead the system
into an ill-deﬁned state.
The PrPsc polymer equation
Next we write the rate equations for the PrPsc polymers. The
elementary processes as described at the end of the In-
troduction give rise to the kinetic equations for the number of
PrPsc polymers of length i $ n,
dyi
dt
¼ bxyi1  bxyi  ayi  bði 1Þyi1 2b +
‘
j¼i11
yj: (2)
The ﬁrst term at the right-hand side of Eq. 2 describes the
growths of the number of PrPsc polymers of size i when
a monomer reacts with a PrPsc polymer of size i – 1 (process
f2g), transforming it into a polymer of size i. Similarly, the
second term describes the reaction of a polymer of size i with
a monomer which transforms it into a polymer of size i 1 1
by reducing the number yi. The third term describes the
degradation of PrPsc polymers independent of their size
(process f4g), with the rate a  d. The fourth term refers to
all possible splittings of the polymer of size i, which leads to
decreasing yi. Indeed, the total rate of all possible splittings
of polymer i into pieces of l and i – l with equal rate b reads
+
n1
l¼1
byi ¼ byi +
n1
l¼1
1 ¼ ði 1Þbyi: (3)
Finally, the last term describes the process when a polymer
of size j splits into two pieces—one of length i, and the other
one which may be of any size. Again, the rate constant
b doubles, since the piece imay be split from both ends of the
polymer.
Important characteristics of the size-polydisperse PrPsc
polymer solution are the total number of polymers y and the
total number of monomers which are contained in the
abundance of these polymers z as
y[ +
‘
i¼n
yi; z[ +
‘
i¼n
iyi; (4)
where z is proportional to the total mass of PrPsc.
An equation for ymay be obtained by summing up all Eqs.
2 for all polymer sizes i:
dy
dt
¼+
‘
i¼n
dyi
dt
¼ b+
‘
i¼n
ðxyi1 xyiÞa+
‘
i¼n
yi b+
‘
i¼n
ði1Þyi12b+
‘
i¼n
+
‘
j¼i11
yj
¼ayðbzbyÞ12bðznyÞ
¼ay1bz1ð12nÞby: (5)
To simplify Eq. 5, we use the deﬁnitions from Eq. 4 and the
identity of
+
‘
i¼n
ðyi1 yiÞ ¼ +
‘
i¼n1
yi+
‘
i¼n
yi ¼ 0; (6)
which holds true, inasmuch as yn–1 ¼ 0. The last term in Eq.
5 simpliﬁes as
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+
‘
i¼n
+
‘
j¼i11
yj ¼+
‘
i¼n
+
‘
j¼n
yjQð j iÞ ¼+
‘
j¼n
yj+
‘
i¼n
Qð j iÞ ¼+
‘
j¼n
yj+
j1
i¼n
1
¼+
‘
j¼n
yjð jnÞ ¼ zny; (7)
where the step-function is deﬁned by
QðkÞ ¼ 1 if k[0
0 if k#0:

(8)
With Eqs. 6–7 we arrive at
dy
dt
¼ bzð2n1Þby ay: (9)
Similarly, multiplying the ith equation in Eq. 2 by i and
performing the summation we obtain an equation for z(t) of
dz
dt
¼bxyazbnðn1Þy: (10)
Although the equation for the number of monomers was
incomplete inMasel et al. (1999), Eqs. 9 and 10 coincide with
those obtained there. This does not mean that the time
dependence of the number of polymers y(t) and their total
mass z(t) is identical to previous results, since the number of
monomers, x(t), enters the equations for y and z.Wewill show
below that the evolution of y(t) and z(t) is even qualitatively
different from that of the model by Masel et al. (1999).
Collecting the results of this section, we give the set of
equations that govern the evolution of the system:
_x¼ ldxbxy12b+
n1
j¼1
+
‘
i¼n1j
jyi12b+
n1
j¼1
+
n1j1
i¼n
iyi;
_y¼ay1bz1ð12nÞby;
_z¼bxyaz bnðn1Þy: (11)
Unfortunately, with the correct kinetic equation for the
monomers it is not possible to obtain a closed solution for the
variables x, y, and z. In general, the evolution of monomers x
depends not only on the total number of polymers y and their
total mass z, but on the full distribution yk, which is unknown.
We will come back to this issue in The Effect of Filtering.
KINETIC EQUATIONS FOR CONSTANT NUMBER
OF MONOMERS
Simpliﬁed set of equations for x(t ) 5 x0 5 const
The analysis of the kinetic equations in Eq. 11 simpliﬁes
considerably if one assumes that the number of PrPc
monomers is kept constant by some regulatory processes
in the cell:
xðtÞ ’ x0¼ const: (12)
With this assumption, the rates in Eq. 11 simplify to a set of
linear equations:
_y¼ay1bz1ð12nÞby
_z¼ bx0yazbnðn1Þy; (13)
which may be solved exactly. The solution reads (Masel and
Jansen, 2001),
zðtÞ ¼ c1 expðr1tÞ1c2 expðr2tÞ (14)
yðtÞ ¼ d1 expðr1tÞ1d2 expðr2tÞ (15)
with
r1=2 ¼abn1 b
2
6
1
2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
b
214bbx0
q
: (16)
In realistic systems we have r1 [ 0, r2 \ 0 (Masel and
Jansen, 2001). The constants c1, c2, d1, and d2 are speciﬁed
by the initial conditions, i.e., they may be expressed in terms
of y(0) and z(0):
d1¼ yð0Þ½ð12nÞb r2 a1bzð0Þﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
b
214bbx0
p ; d2¼ yð0Þd1
c1¼ yð0Þ½bx0bnðn1Þ zð0Þða1r2Þﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
b
214bbx0
p ; c2 ¼ zð0Þ c1:
(17)
Hence, the time-dependence of y(t) and z(t) is described by
two exponents, r1 and r2.
PrPsc polymer size distribution
The equations for the number of polymers with different
degree of polymerization may be found iteratively. The
evolution of yn(t) is characterized by three exponents, yn11
by four exponents, and generally, yn1k(t) by k 1 3 expo-
nents. To show this, we apply the Laplace transformation
y˜kðsÞ ¼
ð‘
0
e
st
ykðtÞdt (18)
to the kinetic Eq. 2 for the number of polymers. We use the
property of the Laplace transform dyk=dt ! sy˜kðsÞ  ykð0Þ
and write +‘
j¼i11yj as y+
i
j¼nyj. Then the Laplace trans-
form of yk reads
y˜kðsÞ ¼ ykð0Þ1 2by˜ðsÞ  ð2b bx0Þy˜k1ðsÞ  2by˜k2ðsÞ     2by˜nðsÞ
s1 ½bx01 a1 bðk1 1Þ : (19)
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Inasmuch as the Laplace transform of y(t) and z(t) is given by
y˜ðsÞ ¼ d1
s r1 1
d2
s r2 and z˜ðsÞ ¼
c1
s r1 1
c2
s r2 ; (20)
y˜kðsÞ may be expressed by means of Eq. 19 in terms of y˜jðsÞ
with j\ k. Hence, Eq. 19 allows for an iterative solution for
the complete polymer size distribution, starting from y˜n ( yj¼
0 for j\ n). It reads
y˜nðsÞ ¼ ynð0Þ
s1an
1
2bd1
ðs r1Þðs1anÞ1
2bd2
ðs r2Þðs1anÞ ; (21)
where we introduce the short-hand notation, ak[ bx01 a1
b(k 1 1). The inverse Laplace transform for these simple
fractions (which correspond to the basic inverse Laplace
transforms; Abramowitz and Stegun, 1964) reads as
ynðtÞ ¼AðnÞ0 eant1Bnejr2 jt1Cner1t; (22)
with
A
ðnÞ
0 ¼ ynð0Þ1Bn1Cn
Bn ¼ 2bd2
r21an
Cn ¼ 2bd1
r11an
; (23)
where we take into account that r2\ 0. As it follows from
Eq. 22, the evolution of yn is described by three exponential
functions. Similarly, y˜n11ðsÞ may be expressed in terms of
y˜nðsÞ and y˜ðsÞ. Performing the inverse Laplace transform for
this quantity yields
yn11ðtÞ ¼ Aðn11Þ0 eant1Aðn11Þ1 ean11t1Bn11ejr2 jt1Cn11er1t;
(24)
where the coefﬁcient A
ðn11Þ
0 depends on yn(0), A
ðn11Þ
1 on
yn(0) and yn11ð0Þ, whereas the coefﬁcients Bn11 and Cn11
depend only on y(0) and z(0). The expressions for these
coefﬁcients are derived in Appendix B.
Thus, yn11(t) is expressed by four exponents. This iter-
ative procedure may be continued to ﬁnd successively all
yk(t), i.e., the complete polymer size distribution. Using Eqs.
22 and 24 and the iterative scheme, one obtains the time-
dependence of the polymer size distribution,
yi ¼ +
in
k¼0
AðiÞk e
an1kt1Bie
jr2jt1Cie
r1t; (25)
where Ak
(i), Bi, and Ci are constants and the coefﬁcients aj
have been deﬁned above. As already mentioned, for realistic
parameters r1[0 and r2\0, thus in the series of expressions
in Eq. 25 only the last term Cie
r1t has a positive exponent and
grows with time. Therefore, after a transient time which is
considerably shorter than the incubation time (Masel and
Jansen, 2001), all terms with negative exponents may be
neglected. This means that the system evolves independently
of its initial conditions and the distribution of PrPsc polymer
sizes has achieved its steady-state form. Neglecting the
amplitudes Ak
(i) and Bi, one obtains expressions for the
coefﬁcients Ci. Solving this equation (details are given in
Appendix B), one obtains the steady-state distribution for the
normalized size distribution wi ¼ yi/y:
wi ¼ qiqi11
qn
qk¼ ðk1n0Þen2ðk1n0Þ
2
=2
; (26)
where
n0¼ ða1r11bÞ=b and n2¼ b=bx0: (27)
Fig. 2 shows the analytical result, Eq. 26, together with the
results of a numerical simulation. The details of the sim-
ulation method are given in Appendix A.
Evolution of the average size of PrPsc polymers
and scenarios of PrPsc evolution
We introduce the average size of PrPsc polymers as s(t) ¼
z(t)/y(t). Both y(t) and z(t) have the same time-dependence
after the transient time, which corresponds to exponential
growth with the exponent r1 as given in Eq. 16. Therefore,
the average size is time-independent after this transient time.
From the set of equations in Eq. 13 for y(t) and z(t) follows
the equation for s:
ds
dt
¼ 1
y
dz
dt
 z
y
2
dy
dt
¼bx0bnðn1Þ1bð2n1Þsbs2
(28)
¼ g1bð2n1Þsbs2: (29)
Equation 29 deﬁnes the value of g ¼ bx0 – bn(n – 1).
The solution of Eq. 28 reads
FIGURE 2 Distribution of polymers wi [ yi/y over the polymer length i
for ﬁxed number of monomers x0 ¼ 500. We obtain excellent agreement
between the analytical result Eq. 26 (line) and the results of a numerical
simulation (circles). The parameters are n ¼ 6, a ¼ 0.05, b ¼ 93 104, and
b ¼ 0.015.
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sðtÞ ¼ n1
2
1
r1 r2
2b
3 tanh
r1 r2
2
t1
1
2
ln
ðr1 r2Þ1bð12n12sð0ÞÞ
ðr1 r2Þbð12n12sð0ÞÞ
  
;
(30)
with s(0) being the initial average length of PrPsc polymers.
The evolution of the average size as described by Eq. 30 is
drawn in Fig. 3 together with the results of a numerical
simulation of the stochastic model. Solving the steady-state
equation
_s¼ g1bð2n1Þsbs2¼ 0; (31)
we obtain for the steady-state average size
s1;2¼ n1
2
6
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
bx0
b
1
1
4
r
: (32)
The number of PrPsc molecules y(t) can also be expressed in
terms of the average polymer size s(t). From Eq. 13 follows
dy
dt
¼ bðs s*Þy with s*¼ ð2n1Þ1 a
b
: (33)
The velocity of growth of the average size _s as a function of
the average size s is drawn in Fig. 4. For the given set of
parameters the values of s1/2 and s* are marked. We see that
only the steady-state solution s1 corresponds to a stable
ﬁxpoint (moreover, for the chosen set of parameters, s2 is
negative).
From Eq. 33 one can conclude that there exist several
scenarios of the system evolution, depending on the initial
mean size of polymers s(0) (see Figs. 5 and 6).
The last three cases (Fig. 6) correspond to decay of the
total number of polymers to zero. Any inoculation for the
corresponding sets of parameters does not lead to spreading
of the disease. The condition of complete recovery of an
infected organism reads s1\ s*, or in terms of the number of
monomers,
x0\x*; (34)
where
x*¼ b1b n1 a
b
 	
n11 a
b
 	
: (35)
Contrarily, if the condition of Eq. 34 does not hold, any
inoculation of PrPsc polymers leads to infection, even if the
inoculation is inﬁnitesimally small, e.g., consists of a single
molecule. Certainly this is not realistic and demonstrates that
the application of continuum differential equations has a
restriction. These deal with the average numbers and ignore
their ﬂuctuations. For very dilute systems the ﬂuctuations of
the numbers of molecules are of the same order as the
numbers themselves and one has to use a stochastic model,
which is employed in the present study (see Appendix A).
THE FULL SET OF KINETIC EQUATIONS, EQ. 11
Evolution of x(t ), y(t ), and z(t )
So far the number of PrPc monomers was kept constant (x(t)
¼ x0), which was attributed to some regulatory process. This
assumption simpliﬁes the analysis of the kinetic equations
yielding the linear set of Eq. 13, which enables us to draw
certain conclusions as shown in the previous sections.
Unfortunately, we are not able to solve the full set of
equations in Eq. 11 including the time-dependence of PrPc
monomers in a closed form. Nevertheless, it is possible to
investigate the process sketched in Fig. 1 numerically using
a stochastic method, such as the Gillespie algorithm
(Gillespie, 1976; Feistel, 1976, 1977; see also Appendix A,
this article).
Numerical simulations show that after the initial expo-
nential growth of the number of polymers and of their total
mass, the supply of monomers (which occurs at the constant
rate l) is not large enough to support further exponential
growth. The system relaxes to the steady state at which the
process of PrPsc decay is completely compensated by the
process of their production from PrPc monomers. After the
exponential growth ceases, the number of monomers as well
FIGURE 3 Evolution of the average size s ¼ z(t)/y(t) of PrPsc polymers
due to Eq. 30 (line) and results of a simulation (circles). The parameters are n
¼ 6, a ¼ 0.05, b ¼ 9 3 104, and b ¼ 0.015. The initial size is s(0) ¼ 10.
FIGURE 4 The average growth velocity _s over the average size s due to
Eq. 29. The parameters are n ¼ 6, a ¼ 0.015, b ¼ 0.0009, b ¼ 0.025, and
x0 ¼ 500.
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as the number of polymers reach relatively fast their steady-
state value x(t) ¼ xst and ykðtÞ ¼ ðykÞst. The same happens to
the total number of PrPsc polymers y(t) and to their total mass
z(t), which also achieve their steady-state values, yst and zst.
The expressions in Eq. 11 read for the steady-state case,
when _x ¼ _y ¼ _z ¼ 0, and x ¼ xst, y ¼ yst, z ¼ zst,
ayst1bzst1ð12nÞbyst ¼ 0
bxstystazstbnðn1Þyst ¼ 0: (36)
From the ﬁrst equation in Eq. 36 we ﬁnd the steady-state
value of the average size of PrPsc polymers,
sst ¼ zst=yst ¼ a=b1ð2n1Þ; (37)
which, substituted into the second equation in Eq. 36, yields
the steady-state number of monomers,
xst ¼ b1½a2=b1ð2n 1Þa1nðn1Þb ¼ x*: (38)
The evolution of the number of monomers and of the average
size of polymers is drawn in Figs. 7 and 8.
Note that xst equals the threshold value for the number
of monomer x* for the model with ﬁxed x ¼ x0. This is
not surprising, inasmuch as x* separates two regimes of
exponential decay and exponential growth of the abundance
of PrPsc; thus, x ¼ xst ¼ x* corresponds to the number of
monomers which keeps the abundance of PrPsc constant.
Due to the time-dependence of the number of monomers
x(t), the evolution of the number of PrPsc polymers y(t) and
their total mass z(t) becomes more complicated (see Fig. 9):
The initial exponential growth ﬁnally completely ceases and
y(t) and z(t) saturate at their steady-state values. Between the
exponential growth and saturation one observes a nearly
linear growth.
Steady-state PrPsc polymer size distribution
The steady-state distribution of the PrPsc polymer sizes may
be obtained exactly in the same way as for the case of x(t) ¼
x0. The only difference is that instead of x0 one has to use
now xst, given by Eq. 38, and that the growth rate is zero, i.e.,
the value of r1 ¼ 0 is to be taken. Performing the same
derivation as presented in Appendix B, but with r1 ¼ 0, we
obtain the steady-state size distribution wi ¼ yi/y of PrPsc
polymers:
wi ¼ qiqi11
qn
qk¼ ðk1n90Þen92ðk1n90Þ
2
=2
; (39)
FIGURE 5 PrPsc polymer growth scenarios for the case s*\ s1. The parameters are n ¼ 6, a ¼ 0.05, b ¼ 9 3 104, and b ¼ 0.015, which corresponds to
s* ¼ 66.44 and s1 ¼ 96.78. (Top) s(0)\ s* (y10(0) ¼ 53 105); (middle) s(0)[ s* (y25(0) ¼ 83 103); and (bottom) s(0)[ s1 (y200(0) ¼ 25,000). In all cases
the initial inoculation is z(0) ¼ 5 3 106.
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with the modiﬁed coefﬁcients
n90 ¼ ða1bÞ=b and n92¼ b=bxst: (40)
As it follows from Eq. 39, the steady-state distribution is
shifted now to smaller polymer sizes as compared to the
previous case of x ¼ x0 (see Eq. 26), where we assumed that
the number of PrPc monomers was kept constant due to some
external regulatory process. The size distribution due to Eq.
39 is drawn in Fig. 10.
In Fig. 7 we have drawn the evolution of the number of
PrPc monomers x(t). The rates which are related to the
stochastic growth, degradation, and splitting of the PrPsc
polymers are much smaller than the rates of production and
degradation of PrPc monomers, l and d, respectively (see
Masel et al., 1999). This fact gave rise to the assumption
of a time-independent number of monomers x(t) ¼ x0 ¼
l/d which was exploited in the previous sections. In-
FIGURE 6 PrPsc polymer growth scenarios for the case s*[ s1. The parameters are the same as in Fig. 5 except for a ¼ 0.1, which corresponds to s* ¼
122.11 and s1¼ 96.76. (Top) s(0)\ s1 (y10(0)¼ 53 105); (middle) s*[ s(0)[ s1 (y100(0)¼ 53 104); and (bottom) s(0)[ s* (y500(0)¼ 104). In all cases the
total initial inoculation is z(0) ¼ 5 3 106.
FIGURE 7 Evolution of the number of monomers x¼ x(t). The simulation
starts with x(0)¼ 100 monomers and relaxes within a very short time (which
is not visible on the timescale of the ﬁgure) to x(t) 500. This corresponds to
the number of monomers x0 ¼ l/d which provides the initial exponential
growth. According to a complicated dynamics it eventually approaches its
steady-state value xst ¼ 222.211 given by Eq. 38 (dashed line). The
parameters are n ¼ 6, a¼ 0.05, b¼ 93 104, b ¼ 0.015, l¼ 200,000, and
d ¼ 400.
FIGURE 8 Evolution of the average size of PrPsc polymers s ¼ z(t)/y(t).
The simulation starts with s(0) ¼ 200. The dashed line shows the analytical
result, Eq. 37. The parameters are given in the caption of Fig. 7.
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deed, shortly after the beginning of the simulation, x(t) re-
laxes to its assumed steady-state value x0. For later times,
however, one observes a further relaxation to a ﬁnal steady
state.
Evolution of the PrPsc size distribution
In the previous subsection, we have investigated the steady
state of the PrPsc polymer size distribution. For the spreading
of the sickness it may be interesting to know the evolution of
the size distribution after an inoculation. In Fig. 11 we have
drawn the size distribution at particular times after an
inoculation of 435 PrPsc polymers of length 50 each, i.e.,
y50(0)¼ 435. Hence, the total initial PrPsc mass is z(0)¼ 435
3 50 ¼ 21750, which is ;1/100 of the steady-state value as
can be seen from Fig. 9 (right). The curves are drawn at time
instants t  0, t  4, t  16, t  64, t  256, and t  1024.
During the relaxation the distribution shifts signiﬁcantly to
the right, i.e., larger polymers occur preferably. This explains
the maximum in the evolution of the average size as drawn in
Fig. 8.
The effect of ﬁltering
One may raise the question of how the initial PrPsc length
distribution affects the spreading of the disease. To this end
we made simulations with identical masses of the initial
inoculation, z(0) ¼ 16,000, but with different size distribu-
tions. We have chosen three initial distributions, displayed in
the top row of Fig. 12. For the simplest one we use a delta-
like distribution, y40(0) ¼ 400 (left). As the system evolves it
approaches the steady-state distribution as given above (Fig.
10). In Fig. 12 (bottom left) we show the size distribution at
the time instant t ¼ 16.1 days when the total mass reaches
z ¼ 2 3 106. For the reasons explained below we use this
total mass as the mass accumulated after the incubation time,
i.e., z(tinc)¼ zinc¼ 23 106. Then this distribution yi(tinc) was
used to generate two other distributions: the ‘‘natural’’
distribution, yi(0) ¼ yi(tinc)/125 (top middle in Fig. 12) and
the ‘‘ﬁltered’’ distribution, yi(0) ¼ 0 for i[ 50 (top right in
Fig. 12), preserving the total initial mass z(0). The dashed
lines show the (accordingly scaled) distribution yi(tinc) which
refers to the assumed incubation time. The second row in
Fig. 12 shows the according distributions at the incubation
time t ¼ 16.1. One notes that at this stage, the initial
distribution is already completely relaxed, i.e., there is no
signiﬁcant difference between all the three distributions. The
initial distribution does, however, affect the growth of the
total mass of PrPsc molecules. Fig. 13 shows the total mass
of polymers over time corresponding to the three different
initializations.
It was shown that infected mice develop symptoms of the
sickness as soon as there is a certain level of PrPsc in their
brain, independently of the incubation period and the amount
of initial inoculation (Manson et al., 1994; Bu¨eler et al.,
1994). Therefore, one may deﬁne the incubation time tinc as
the time when a certain mass of PrPsc molecules, z(tinc) ¼
zinc, is achieved after an initial inoculation at time t ¼ 0. In
Fig. 13 we have marked the times tinc after which the mass
zinc ¼ 2 3 106 was reached for our three different initial
distributions. As it has been already mentioned the initial
stage of the disease corresponds to exponential growth of
the prion abundance. For the chosen set of the model parame-
ters in Fig. 13, the exponential growth corresponds to the
doubling time of ;2.5 days. This is consistent with the
experimental data by Beekes et al. (1996), Taylor et al.
(2000), Kimberlin and Walker (1977, 1980, 1986), and
Kimberlin et al. (1983), where doubling time in the range of
FIGURE 9 Evolution of the number of
PrPsc polymers y(t) (left) and the total
mass of polymers z(t). For comparison,
the dashed lines show the solution of the
simpliﬁed set of equations, Eq. 14, with
the exponents and coefﬁcients given by
Eqs. 16 and 17, respectively, with x0 ¼
l/d. The parameters of the simulation are
given in the caption of Fig. 7.
FIGURE 10 Size distributions of PrPsc polymers for the full model,
including x ¼ x(t). The points display numerical simulations and the line
shows the analytical result, Eq. 39. The parameters of the simulation are
given in the caption of Fig. 7. For comparison, the dashed line shows the
result for the simpliﬁed model with x(t) ¼ l/d ¼ const. due to Eq. 26.
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2–7 days has been reported. Naturally, the exponential
growth of the aggregate mass implies linear dependence of
the incubation time on the logarithm of the initial dose
(Masel et al., 1999). Note, however, that in Fig. 13 the initial
dose z(0) is the same for all shown curves; the inoculation
differs only by the initial size distribution of the polymers.
To illustrate qualitatively the incubation time-dependence on
the initial distribution we have chosen zinc ¼ 23 106, which
approximately corresponds to 2 LD50 doses (Beekes et al.,
1996) and to tinc ¼ 16.1 days. The ratio zinc/z(0) ;1/125 and
the incubation time are signiﬁcantly smaller than those
detected in experiments. The experimental incubation time
may be 103 larger, whereas the ratio zinc/z(0) may be as
large as 1012 for low initial doses (see, e.g., Beekes et al.,
1996; Taylor et al., 2000). In our simulation, the ratio zinc/
z(0) corresponds to seven doublings—whereas in experi-
ments,;20–30 doublings are observed. This ratio, however,
is far beyond the abilities of the present computer model
based on the Gillespie algorithm. Hence for the qualitative
analysis we use the above values for tinc and zinc, which can
be called ‘‘model’’ values.
Since the initial size distribution affects the growth of the
total PrPsc mass, one may ask the question of how ﬁltering
the inoculated material affects the evolution of the total mass
and, hence, the incubation time. By ﬁltering at a level k
(which is to eliminate PrPsc polymers whose length exceeds
FIGURE 11 Evolution of the size distribution for the initial condition y50(0) ¼ 435, yi(0) ¼ 0 for i 6¼ 50. The parameters of the simulation are given in the
caption of Fig. 7.
FIGURE 12 Inﬂuence of the size distribution of the inoculation to the evolution of the distribution. The parameters are n ¼ 6, d ¼ 100, a ¼ 0.027, b ¼
0.0048, l ¼ 106, and b ¼ 0.025. For explanation, see text.
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k) from the distribution yi(tinc), corresponding to the
incubation time, and by preserving the total mass of the
inoculated material, i.e.,
yi ¼ Cwi for i# k0 for i[k;

(41)
where wi ¼ yi(tinc)/y(tinc), the normalization constant C is
determined by
C¼ zð0Þ
+
k
i¼n iwi
; (42)
which assures that the initially inoculated mass z(0) does not
depend on the degree of ﬁltering k. Fig. 14 shows the
incubation time over the degree of ﬁltering. The critical mass
of PrPsc material, i.e., the mass which determines the
incubation time, has been chosen as before, zinc ¼ 2 3 106.
As it is seen from Fig. 14 the sickness develops faster if the
inoculation consists of shorter PrPsc aggregates. This effect
has a simple explanation: the same amount of the PrPsc
aggregates contains more active ends if it is composed of
shorter chains, therefore, the growth occurs more rapidly.
For very short molecules, however, when the typical size
only slightly exceeds the stable minimum n, one could
expect an increase of the incubation time. This may happen,
because at the very beginning of the process any splitting of
the polymer would lead to its complete disintegration and
thus to reduction of the number of growing entities. We do
not see the latter effect, however, for the chosen parameters
of the simulation.
Hence, for experimental purposes, the production of PrPsc
may be enhanced by subdividing long PrPsc chains into
several smaller pieces, e.g., by application of ultrasonic
treatment.
COMPARISON WITH EXPERIMENTS
The developed mathematical model can be checked by
comparing the theoretical results with available experimen-
tal data. As shown above, the assumption of a constant
concentration of monomers, being a basic hypothesis of the
theory by Masel et al. (1999) and Masel and Jansen (2001),
implies qualitatively different scenarios of the disease as
compared to the solution of the full set of kinetic equations in
Eq. 11 where the concentration of monomers is time-de-
pendent. The comparisonwith experimental data can discrim-
inate between these scenarios.
The most striking difference between these models is the
time-dependence of the number of polymers y(t) (or of the
total mass of polymers z(t)). For the simpliﬁed model x(t) ¼
x0, which corresponds to the set of equations Eq. 13, there
exist two possible scenarios in dependence on the model
parameters: unlimited exponential growth of the number of
prion ﬁbrils (i.e., of y(t) or z(t)); or their complete exponential
disappearance. The possible scenarios for this simpliﬁed
model have been illustrated in Fig. 5 (inﬁnite growth) and in
Fig. 6 (complete die-off). Contrarily, the solution of the full
set of kinetic equations in Eq. 11, i.e., including the time-
dependence of the number of monomers, shows initially
intensive growth of the number of polymers y(t), but later it
saturates at some constant value.
If the onset of clinical disease, or of the death of the
infected animal occurred at a time which corresponds to the
stage of exponential growth of the number of polymers, it
would be difﬁcult to discriminate between the models by
means of experimental data. This is deﬁnitely the case for
Beekes et al. (1996), Taylor et al. (2000), Kimberlin and
Walker (1977, 1980, 1986), and Kimberlin et al. (1983),
where a linear dependence of the incubation time on the
logarithm of the initial dose has been reported.
Fortunately, however, there exist experiments which show
saturation of the number of polymers. Rubenstein et al.
(1991) infected mice by intracerebral injection as well as by
intraperitoneal injection with a mixture of scrapie-associated
ﬁbrils (SAFs) of different size. Then the number of the SAFs
was directly measured by negative-stain electron microscopy
at various times after the inoculation. The details of the
FIGURE 13 Total mass of PrPsc molecules, z(t) over time for different
initial size distributions as shown in Fig. 12. The initial total mass, z(0) ¼
16,000, is identical in all cases. The full line corresponds to the left plot in
Fig. 12, the dashed line to the middle plot, and the dotted line to the ﬁltered
inoculation drawn in the right plot.
FIGURE 14 The incubation time is sensitive to the size distribution of the
inoculation. The ﬁgure shows the model incubation time over the level of
ﬁltering as deﬁned by Eq. 41 for an identical number of PrPsc units in the
inoculation, i.e., for the same value of z(0).
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infective material and the puriﬁcation procedure are given by
Rubenstein et al. (1991). In these data we clearly observe
a saturation of the total mass of the prion polymers—i.e., the
data supports our model.
Fig. 15 compares the prediction of our theory with the
experimental data given by Rubenstein et al. (1991) for
the time-dependent abundance of SAFs after intracerebral
inoculation. In Fig. 16 we show the comparison of the
theory and experiment for intraperitoneal inoculation. Again
we see that the experiment supports the model of variable
monomer concentration. This conclusion needs some ex-
planation. First, due to the large scattering of the ex-
perimental data, one can also use a nonsaturating curve,
which corresponds to the exponential growth. However, the
best exponential ﬁt corresponds to a doubling time of ;25
days which is not consistent with the experimentally
observed doubling time. Second, we do not take into ac-
count a possible time lag due to spatial propagation of the
infective material. For the experimental data shown in Figs.
15 and 16 there is no qualitative difference between the cases
of intracerebral and intraperitoneal inoculation. If the time
lag was important, one would expect much more pronounced
difference between two distinct routes of delivery of the
infective material to the spleen. This has been also conﬁrmed
by independent measurements of the evolution of the number
of PrPsc polymers in the brain which resembles its evolution
in the spleen. The saturation of the curves in this case is
clearly visible, too (see Figs. 2 and 3 in Rubenstein et al.,
1991).
Unfortunately, owing to a lack of any reliable data for the
prion size distribution, we cannot compare our theoretical
prediction with experiments. Since the model of variable
monomer concentration leads to a growth law y(t) which
agrees with experimental data, we conclude that this model
leads also to the appropriate size distribution function.
Hence, we believe that the size distribution of the ﬁbrils is
given by Eq. 39 rather than by Eq. 26.
CONCLUSION
Based on the model of Masel et al. (1999) we have derived
a mathematically complete set of equations which describes
the PrPsc ﬁbril growth. We analyze these equations both
analytically and by means of numerical simulations. First
we have considered a simpliﬁed set of equations where the
number of PrPc monomers is assumed to be constant (x ¼
const.), i.e., the concentration of monomers is kept constant
by regulatory processes in the cell. The full set of kinetic
equations for the PrPsc evolution includes the time-depen-
dence of the monomer concentration, which is determined
self-consistently by the rate constants of the system.
We have observed that, depending on the kinetic
parameters, there exist several scenarios of the evolution of
the disease. For the simpliﬁed model (x ¼ const), there are
two possible scenarios: unlimited exponential growth of the
ﬁbril abundance, or their complete disappearance. Con-
trarily, for the model of variable number of monomers (x ¼
x(t)), the initial exponential growth of the number of PrPsc
polymers ceases and ﬁnally the number of PrPsc saturates.
We have analyzed the evolution of the distribution of
the ﬁbril sizes and obtain analytical expressions for the
distribution for both models, x ¼ const and x ¼ x(t). By
numerical simulations we have studied the inﬂuence of
ﬁltering of the inoculation material on the incubation period.
Filtering in this sense means to vary the size distribution of
the inoculation dose by keeping its total mass z0 constant. It
turns out that the incubation time is very sensitive to the size
distribution of the ﬁbrils: keeping the mass of the inoculation
constant it can vary by a factor of ﬁve when the size dis-
tribution varies. This result conﬁrms the importance of
ﬁltering in the inoculation and may be checked experimen-
tally.
FIGURE 16 The same as Fig. 15, but for the intraperitoneal inoculation.
The parameters are n ¼ 6, a ¼ 0.018, b ¼ 3.23 104, b ¼ 0.32, l ¼ 1170,
and d ¼ 140.
FIGURE 15 Time-dependent number of PrPsc polymers as it follows from
the numerical simulation of the set of equations in Eq. 11, including the time-
dependence of the number of monomers ( full line) together with the
experimental data ( points) (Rubenstein et al., 1991). The abundance of the
ﬁbrils (given in this reference as a number of PrPsc per a square element of
the substrate) was obtained by negative-stain electron microscopy at various
times after intracerebral inoculation. The measurements were performed for
the spleens of Compton white mice and C57BL/6j mice. The dashed line
show the prediction of the simpliﬁed model with the same rate constants but
with a constant number of monomers, x0 ¼ l/d; see Eq. 13. The parameters
are n ¼ 6, a ¼ 0.027, b ¼ 4.8 3 104, b ¼ 0.8, l ¼ 1080, and d ¼ 215.
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We compare the prediction of our theory with the
available experimental data for the time-dependence of the
number of PrPsc polymers after an inoculation. These ex-
periments strongly support the need to consider the prion
ﬁbril growth including the time-dependence of the PrPc
monomer concentration as described by the set of equations
in Eq. 11. This model predicts saturation of the number of
PrPsc polymers as compared to unlimited exponential
growths for the simpliﬁed model where the number of PrPc
monomers is kept constant.
APPENDIX A: NUMERICAL SIMULATIONS
We have simulated the model for PrPsc polymer kinetics using a numerical
method which has been developed independently by Gillespie (1976) and
Feistel (1976, 1977). The system can be described as a Markov process, i.e.,
the transition probability from the present state ~S to a state ~S9 depends
exclusively on the present state but not on the earlier history of the system.
The state of the system is characterized by the number yi of polymers of
length i and the number of monomers x, i.e., ~S ¼~Sðx; yn; yn11; . . .Þ. If at
a certain time the system is in state ~S, this state can be left for any of the
following destinations:
1. x11; yn; yn11; . . . with ratel;
2. x  1; yn; yn11; . . . with rate dx;
3. x; yn; . . . yk1; yk  1; yk11; . . . for k ¼ n; n11; n12 . . . with rate ayk;
4. x  1; yn; . . . yk1; yk11; yk11; . . . for k ¼ n; n11; n12; . . . with rate
bxyk ;
5. x; yn; . . . yk11; . . . yl11; . . . ym  1; . . . ðk1l ¼ mÞ for l$ k$ n;
6. x1k; yn; . . . yk; . . . yl11; . . . ym  1; . . . ðk1l ¼ mÞ for k\n# l;
7. x1k1l; yn; . . . yk; . . . yl; . . . ym1; . . . ðk1l ¼ mÞ for k\n; l\n:
The processes 5–7 correspond to the splitting of a polymer of size m. The
rates at which these processes occur depend on the length of the polymer
chain m. They are given in Table 1.
A polymer of length m may be cut at m – 1 positions and it was assumed
that these cuts occur at equal rate b. Since at state~S the system contains ym
molecules of size m the total rate of all possible transitions of types 5–7 in
which a polymer of size m splits is b(m – 1)ym (see also discussion of Eq. 3).
For simulations it is sufﬁcient to determine the size m of the polymer
which breaks in the next simulation step at rate b(m – 1)ym due to the
algorithm described below. Once m is determined one selects the position of
the break, i.e., the ﬁnal lengths l and k, randomly due to an equidistribution.
Depending on their sizes for l\ n, k\ n these pieces either disintegrate by
increasing the number of monomers x or remain stable by increasing the
number of polymers yl, yk, respectively. This procedure yields precisely the
rates which are given in Table 1.
Performing simulation, we have to decide at current time t at what time t1
t the next transition will take place, and what would be the new state among
all states which are accessible from~S by any of the processes of types 1–7.
Assume at time t that the system is in the state~S. Then p(t, m) deﬁnes the
probability density for the next transition m to occur in the time interval (t1
t, t 1 t 1 dt), leading the system to the state ~S9, i.e., m:~S!~S9. This
transition probability density factorizes as p(t, m) ¼ p0(t)pm. Here p0 is the
probability for no transition occurring during the time interval (t, t 1 t)
whereas pmdt is the probability that during (t1 t, t1 t 1 dt) the state~S is
left via transition m. In our notations m belongs to one of the seven types of
possible transitions which are listed above, thus, each probability pm is
determined by the according rates.
From its deﬁnition, obviously, p0(t) is an exponential distribution
p0ðtÞ ¼AexpðAtÞ; (A1)
where A is the sum of all reaction rates of processes which correspond to
transitions ~S!~S9, where ~S9 is any of the states which are accessible by
a single transition from~S. Hence, A is the total rate to leave the present state
~S. For our model A reads
A¼ l1dx1 +
‘
i¼n
ayi1bx+
‘
i¼n
yi1 +
‘
i¼n
bði 1Þyi: (A2)
In simulations we compute the random value of t obeying the probability
distribution p0(t) (Eq. A1) via
t¼ 1
A
logRND; (A3)
where RND is an equidistributed random number from the interval (0, 1).
The probability pm of the transition m is determined by
pm ¼ Am=A; (A4)
where Am is the rate of the transition m. The numerical procedure to deter-
mine the transition m to escape from the present state~S is sketched in Fig. 17.
With these ingredients we can set up an efﬁcient algorithm for the simu-
lation of the system described by the set of equations in Eq. 11. In detail:
1. Initialize the variables x (number of monomers), yi (number of polymers
of size i), and time t ¼ 0.
2. Compute the time t after which the present state is left according to Eq.
A3.
3. Determine the process by which the present state is left as described by
Eq. A4 and Fig. 17.
4. Modify the variables x and yi according to the chosen process.
5. Update the rates Am according to the modiﬁed variables.
6. Increment time t ! t1 t.
7. Extract interesting data, such as y ¼ + yi, z ¼ +iyi , etc.
8. Continue with step 2.
Simulation techniques of this type have been applied ﬁrst by Gillespie
(1976) and Feistel (1976, 1977).
APPENDIX B: STEADY-STATE DISTRIBUTION OF
THE PRPSC POLYMER SIZES
Assume that the number of monomers is constant and equals x0. Then the
kinetic equation for the numbers of PrPsc polymers of size i is given by
dyi
dt
¼bx0ðyi1 yiÞayibði1Þyi12b +
‘
j¼i11
yj: (B1)
The general solution of this equation reads
yi ¼ +
in
k¼0
A
ðiÞ
k e
an1kt1Bie
jr2 jt1Cie
r1t; (B2)
TABLE 1
Process Rates for m $ 2n – 1 Rates for n # m\ 2n – 1
(5) b(m – 2n 1 1)ym 0
(6) 2b(n – 1)ym 2b(m – n)ym
(7) 0 b(2n – m – 1)ym
Total b(m – 1)ym b(m – 1)ym
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where the coefﬁcients A0
(n), Bn, and Cn for i¼ n, are given by Eq. 23, and for
i ¼ n 1 1 they may be obtained after the second iterative step,
A
ðn11Þ
0 ¼
ðbx0bÞ
b
ynð0Þ 2bd1
r11an
 2bd2
r21an
 
(B3)
A
ðn11Þ
1 ¼ yn11ð0Þ
bx0
b
1
 
ynð0Þ
1bx0
2d1
r11an11
1
2d2
r21an11
 
(B4)
Bn11¼ 2bd2
r21an11
1
2bd2ðbx0 bÞ
ðr21anÞðr21an11Þ
 
(B5)
Cn11¼ 2bd1
r11an11
1
2bd1ðbx0bÞ
ðr11anÞðr11an11Þ
 
: (B6)
Generally, the coefﬁcient A0
(k) depends on yn(0), A1
(k) depends on yn(0) and
on yn11(0), and Al
(k) depends on yn(0), . . . , yn1l(0).
All terms in Eq. B2 except for the last one decay exponentially,
whereas the last one grows exponentially. Thus, after a transient time only
this term is nonvanishing. Therefore we may neglect all terms except for
the last one and ﬁnd the solution in the form yk ¼ Cker1t. Substituting this
expression into Eq. B2 we ﬁnd that the coefﬁcients satisfy the difference
equation
r1Ci ¼ bx0ðCi1CiÞaCibði11ÞCi12b+
‘
j¼i
Cj: (B7)
Now we introduce the quantity
Qi ¼+
‘
j¼i
Cj; (B8)
so that the initial coefﬁcients Ci may be expressed in terms of Qi as
Ci ¼QiQi11: (B9)
The equation for the coefﬁcients Qi reads then as
r1ðQiQi11Þ ¼ bx0ðQi112Qi1Qi1Þ
bði11ÞðQiQi11Þ12bQiaðQiQi11Þ:
(B10)
For i  1 it is reasonable to consider i as a continuous variable, say X and
switch from the difference equation in Eq. B10 to the differential equation.
Then Qi – Qi11 may be written as –dQ(X)/dX and Qi11 – 2Qi 1 Qi–1 as
d2Q(X)/dX2. In this way we can recast Eq. B10 into the form
Q991ðn11n2xÞQ912n2Q¼ 0; (B11)
where
n1¼ a1r11b
bx0
and n2¼ b
bx0
: (B12)
Introducing a new variable,
j¼ ðn11n2XÞ= ﬃﬃﬃﬃn2p ; (B13)
we obtain an equation for Q(j),
Q991jQ912Q¼ 0; (B14)
which after a substitute Q ¼ W exp(–j2/4) yields the equation for the
function W(j),
W991 11
1
2
 j
2
4
 
W ¼ 0; (B15)
which is exactly the equation for the harmonic oscillator in quantum
mechanics, which is also called the parabolic cylinder equation with index
n¼ 1 (e.g., Bender and Orzag, 1978). The general solution to this equation is
the parabolic cylinder function. For n ¼ 1 the solution may be expressed
through Hermite polynomials,
WðjÞ ¼NHe1ðjÞej
2=4
; (B16)
with the constant N to be determined from the boundary conditions. Taking
into account that He1(j) ¼ j (Bender and Orzag, 1978) and returning to the
previously used discrete variable i, we obtain
Qi ¼N ﬃﬃﬃﬃn2p ðn01 iÞen2ðn01iÞ2=2; (B17)
where
n0¼ n1
n2
¼ a1r11b
b
: (B18)
To ﬁnd the constant N we notice that after the transient time
yðtÞ ¼ d1er1t ¼+
‘
j¼n
yj ¼ er1t+
‘
j¼n
Cj ¼ er1tQn¼ d1er1t; (B19)
which yields Qn ¼ d1, or
FIGURE 17 To choose randomly the transition m by which the system escapes from the present state~S we set up an array V containing the cumulative rates,
i.e., V[0] ¼ 0, V[1] ¼ V[0] 1 A1 ¼ V[0] 1 l, V[2] ¼ V[1] 1 A2 ¼ V[1] 1 dx, V[3] ¼ V[2] 1 A3 ¼ V[3] 1 ayn, etc. Then we draw an equidistributed random
number RND from the interval ½0;+Ai. The process i for which V[i – 1]\ RND # V[i] is chosen to be the next process.
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N¼ d1e
n2ðn01nÞ2=2ﬃﬃﬃﬃ
n2
p ðn01nÞ ; (B20)
where d1 is determined by the initial conditions. Using Eq. B9 for the
coefﬁcients Ci, one can write for the normalized distribution
wi ¼ yi
y
¼ ðQiQi11Þe
r1t
Qne
r1t
; (B21)
which with Eq. B17 we rewrite in the ﬁnal form as
wi ¼ qiqi11
qn
qk¼ ðk1n0Þen2ðk1n0Þ
2=2
; (B22)
with
n0¼ a1r11b
b
and n2¼ b
bx0
; (B23)
as deﬁned previously.
The authors are grateful to C. Gille for helpful discussions and to P.
Krapivsky for drawing our attention to the similarity of cow madness and
the quantum harmonic oscillator.
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